TGHC3 Transgender Module 2b: Evidence Based Practice Guidelines and Standards of Care Primary Care Questions and Answers

This article will provide you with the Questions and Answers for TGHC3 Transgender Module 2b: Evidence Based Practice Guidelines and Standards of Care Primary Care.

On June 30, 2016 Secretary of Defense Ash Carter announced that:
c.Transgender individuals will now be able to openly serve in the U.S. armed forces


Patient centered care as defined by the Institute of Medicine (2001) is:
d.Compassionate, empathetic, and responsive to the needs, values, and expressed preferences of the individual patient


Why is it important to create a welcoming clinical environment for transgender patients?
a.This is one strategy for overcoming barriers to care and patients may be more able to openly communicate their healthcare needs


When assessing sexual history, 1. It is okay to make assumptions about sexual behavior and anatomy based upon the individual’s expressed gender; 2. Understand that discussion of genitalia or sex acts may be complicated by discomfort or disassociation with specific anatomy and that the discussion may be stressful to the patient; 3. Try to figure out terms or behaviors with which you are unfamiliar and do not bother the patient by asking for clarification; 4. Explain the purpose of questions if the patient expresses discomfort in responding (Select the best response):
b.2 and 4


Common Treatments and Procedures include:
d.All of the above


Surgeries specific to transgender populations DO NOT include:
b.Orchiectomy


During the physical examination, providers should:
c.Maintain an organ inventory to guide screening and the management of specific complaints


Considerations prior to initiating hormone therapy DO NOT include:
d.Length of time the patient has been engaged with a mental health provider


Which of the following may be effects of male to female hormone therapy, 1. Breast development (usually to Tanner stage 2 or 3), redistribution of subcutaneous fat, reduction of muscle mass, reduction of body hair, change in sweat and order patterns, and arrest and possible reversal of scalp hair loss; 2. Decreases in libido and ability to ejaculate; 3. Reduced testicular size; 4. Changes in emotional and social functioning (Select the best response):
d.1, 2, 3 and 4


Which of the following are effects of female to male hormone therapy, 1. Development of facial hair; 2. Decreased body hair; 3. Redistribution of subcutaneous fat; 4. Clitoral growth and vaginal dryness (Select the best response):
d.1, 3 and 4


Regarding cancer screening:
c.Insufficient evidence exists to determine if transgender individuals have increased or decreased overall risk as well as organ-specific risk

When evaluating coronary artery disease in transgender patients, how might providers choose to use the risk calculator?
a. Depending on the age at which hormones are begun and total length of exposure, providers may choose to use the risk calculator for the natal sex, affirmed gender, or an average of the two.

(Sent via I Hate CBT's)